62087-96-1|Triletide|methyl acetyl-L-phenylalanyl-L-phenylalanyl-L-histidinate|-范德生物科技公司

Triletide

NMR下载 COA and HPLC MSDS下载
names：
methyl acetyl-L-phenylalanyl-L-phenylalanyl-L-histidinate
CAS号：
62087-96-1
MDL Number：
MF(分子式)： C27H31N5O5 MW(分子量)： 505.57
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	methyl acetyl-L-phenylalanyl-L-phenylalanyl-L-histidinate
英文别名	Triletide; Triletidum; Triletida;
CAS号	62087-96-1
Inchi	InChI=1S/C27H31N5O5/c1-18(33)30-22(13-19-9-5-3-6-10-19)25(34)31-23(14-20-11-7-4-8-12-20)26(35)32-24(27(36)37-2)15-21-16-28-17-29-21/h3-12,16-17,22-24H,13-15H2,1-2H3,(H,28,29)(H,30,33)(H,31,34)(H,32,35)/t22-,23-,24-/m0/s1
InchiKey	ZHAGGRWTJXROKV-HJOGWXRNSA-N
分子式 Formula	C27H31N5O5
分子量 Molecular Weight	505.57
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Triletide(CAS:62087-96-1):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Triletide is a thromboxane A2 antagonist.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Repossini L. Preliminary human pharmacokinetics of triletide. Pharmatherapeutica. 1985;4(3 Spec No):189-94. PubMed PMID: 4059299.

[2]d'Ambrosio G, d'Annabile A. Effects of combined treatment with triletide and cimetidine in gastric and duodenal ulcer patients, and a retrospective comparison with cimetidine alone. Pharmatherapeutica. 1985;4(3 Spec No):171-6. PubMed PMID: 4059298.

[3] Trabucchi E, Longoni F, Baratti C, Boccasanta P. Clinical evaluation of triletide versus antacids in the treatment of duodenal ulcer out-patients. Pharmatherapeutica. 1985;4(3 Spec No):161-5. PubMed PMID: 4059297.

[4] Waucquez JL. Dose-finding clinical assay of triletide in gastric and duodenal ulceration. Pharmatherapeutica. 1985;4(3 Spec No):146-54. PubMed PMID: 4059296.

[5] Maggi CA, Ferrari D. Cytoprotective approach to peptic ulcer therapy: a preliminary dose-finding clinical investigation with triletide. Pharmatherapeutica. 1985;4(3 Spec No):141-5. PubMed PMID: 4059295.

6: Gandolfi L, Solmi L. Triletide and ranitidine for the management of chronic duodenal ulcer: a controlled clinical investigation. Pharmatherapeutica. 1985;4(3 Spec No):182-8. PubMed PMID: 3903787.7: Primbs P. Triletide in a cimetidine-controlled clinical evaluation in duodenal ulcer patients. Pharmatherapeutica. 1985;4(3 Spec No):177-81. PubMed PMID: 3903786.8: Campisi D, Cataldo MG, Paterna S, Bivona A, Barbarino C. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone. Pharmatherapeutica. 1985;4(3 Spec No):166-70. PubMed PMID: 3903785.9: Hoetzinger H. Controlled clinical assessment of the efficacy and tolerance of triletide versus antacids in patients with gastric and duodenal ulcers. Pharmatherapeutica. 1985;4(3 Spec No):155-60. PubMed PMID: 3903784.10: Moroni D, Gervasi GB, Patella P, Visentin L, Maselli MA, Bergamaschi M. The tripeptide ZAMI-420 inhibits thromboxane-induced gastric vasoconstriction and ischaemia. Int J Tissue React. 1983;5(3):249-52. PubMed PMID: 6654624.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开